Audentes Therapeutics (BOLD) News Today → Strange new buyer driving up gold (From Stansberry Research) (Ad) Free BOLD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsInsider TradesSocial MediaStock AnalysisCompetitorsInsider TradesSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBold Girlsbbc.co.uk - April 11 at 12:28 PMBoundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplificationsbusinesswire.com - April 11 at 8:00 AMBoundless Bio Inc BOLDmorningstar.com - April 11 at 7:27 AMBoundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024businesswire.com - April 8 at 8:00 AMBoundless Bio Announces Pricing of Initial Public Offeringbusinesswire.com - March 27 at 6:55 PMMarriott Bonvoy Bold credit card review 2023cnn.com - November 25 at 10:27 AMKristen Louelle Is Bold and Beautiful in These 4 Pics in Atlantic Cityyahoo.com - November 4 at 1:32 AMWhat Top 25 upsets are coming this weekend? Bold predictions for Week 5 in college footballusatoday.com - October 27 at 6:28 PMHow Bold Leadership Can Help Or Hurt Youforbes.com - April 27 at 7:53 PMBold Therapeutics Presents Jaw-Dropping Interim Phase 2 Clinical Data for BOLD-100 in the Treatment of Advanced Colorectal Cancer at AACR 2023finance.yahoo.com - April 23 at 9:14 AMThe Benefits of Bold Leadership and How Leaders Can Develop a Bold Mindsetentrepreneur.com - April 18 at 9:14 PMFive bold predictions for the men's NCAA Tournament's Final Fourusatoday.com - April 2 at 9:54 AMMen's NCAA Tournament 2023: 10 bold predictions for March Madnessusatoday.com - March 26 at 7:32 AM5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough Sciencefinance.yahoo.com - March 23 at 12:28 PMTikTok Has A New ‘Bold Glamour’ AI-Powered Filter, Here Are The Risksforbes.com - March 17 at 6:49 PMYou but better? Not so fast. Unpacking TikTok's controversial 'Bold Glamour' filteryahoo.com - March 12 at 11:37 AMOn King's holiday, daughter calls for bold action over wordsnews.yahoo.com - January 18 at 3:25 PMIt's blue Monday... Let's embrace it says JO ELVIN, with this season's refreshingly bold take on the colourdailymail.co.uk - January 17 at 1:43 PMPersonal And Career Success One Bold Move A Dayforbes.com - January 13 at 1:21 PMLeBron exits LA and an American F1 star: our bold sports predictions for 2023theguardian.com - January 5 at 6:36 PMBold predictions for college football's Week 11 have Alabama and LSU on upset alertusatoday.com - November 14 at 12:48 AMLEGO makes bold claim on how bricks affect mental healthnypost.com - October 8 at 12:15 AMBOLD_old Historical Datainvesting.com - August 24 at 11:51 PMFDA approves first fast-acting oral drug for clinical depressionyahoo.com - August 22 at 5:49 PMAppnovation Earns Seven 2022 MUSE Creative Awardsyahoo.com - March 18 at 7:26 AMNemours Children's Health Officially Launches New Brand to Advance Children's Healthfinance.yahoo.com - September 16 at 11:18 PMAstellas' Gene Therapy Trial Hit With Another Death, FDA Slaps Clinical Holdfeeds.benzinga.com - September 14 at 7:12 AM Get Audentes Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BOLD and its competitors with MarketBeat's FREE daily newsletter. Email Address Strange new buyer driving up gold (Ad)One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented." But there's a much better move you can make to get in front of these big moves today. BOLD Media Mentions By Week BOLD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BOLD News Sentiment▼0.000.52▲Average Medical News Sentiment BOLD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BOLD Articles This Week▼00▲BOLD Articles Average Week Get Audentes Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BOLD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Taysha Gene Therapies News Today Editas Medicine News Today Alector News Today C4 Therapeutics News Today Exscientia News Today Tourmaline Bio News Today Fate Therapeutics News Today Mesoblast News Today Replimune Group News Today Voyager Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BOLD) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 MediaMy biggest AI fearParadigm PressHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Audentes Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.